EUCTR2011-003611-37-IT进行中（未招募）不适用
PRevEntion of cardiac and Vascular pEriprocedural complications in patients undergoiNg coronary angiography or angioplasTy: hydratation vs carbonates to prevent Contrast-Induced Nephropathy in patients undergoing coronary angiography or intervention at risk for Heart Failure (PREVENT-CIN HF). A prospective randomized trial. - PREVENT-CINHF
AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA' DI NOVARA0 个研究点目标入组 240 人开始时间: 2012年3月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Consecutive patients undergoing coronary angiography, followed or not by coronary revascularization, at Cath Lab of U.O. of Universitary Cardiology AOU Maggiore della Carità”, Novara.
- •An estimated glomerular filtration rate (GFR) of 60 mL/min or less (calculated by applying the Cockroft-Gault formula) before undergoing coronary angiography.
- •An estimated ejection fraction<40% (transthoracic echocardiogram).
- •Severe mitro-aortic valve disease estimated by transthoracic echocardiogram also in the presence of an ejection fraction >40%.
- •Recent episode af acute pulmonary edema.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 140
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •Inability to obtain consent.
- •Age lower than 18 years old.
- •Pregnancy.
- •Coronary angiography/or revascularisation in emergency.
- •Serious comorbility (shock, cardiac arrest, trauma, etc.).
- •An estimated ejection fraction >40% (transthoracic echocardiogram).
- •Hystory of contrast intolerance.
- •Kidney transplant.
- •Periprocedural complications within 48h after the procedure.
研究者
相似试验
进行中（未招募）
不适用
PRevEntion of cardiac and Vascular pEriprocedural complications in patients undergoiNg coronary angiography or angioplasTy: IntraCoronary Adenosine administration to prevent peRiprocedUral myonecrosiS in elective coronary angioplasty. A prospective double-blind randomized trial (PREVENT ICARUS) trial - PREVENT-ICARUSElective coronary angioplastyMedDRA version: 9.1Level: SOCClassification code 10047065EUCTR2009-013681-92-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
已完成
不适用
Secondary Prevention of Adverse Cardiovascular Events in Cases with Anomalous Origins of Coronary Arteries: Clinical Features, Management, and Long-Term OutcomeAnomalous Origin of the Coronary ArteryJPRN-UMIN000030629ihon University60
进行中（未招募）
1 期
Can the heart drug enalapril prevent heart damage in patients with newly diagnosed breast cancer and lymphoma receiving chemotherapy?Prevention of cardiotoxicityMedDRA version: 20.0Level: PTClassification code 10048610Term: CardiotoxicitySystem Organ Class: 10007541 - Cardiac disordersEUCTR2017-001094-16-GBSouth Tees NHS Foundation Trust170
进行中（未招募）
1 期
High oxygen administration and cardiac complications in colorectal surgeryCardiovascular complications after colorectal surgeryMedDRA version: 20.1 Level: LLT Classification code 10007648 Term: Cardiovascular disease, unspecified System Organ Class: 100000004849MedDRA version: 20.0 Level: LLT Classification code 10050322 Term: Oxygen supplementation System Organ Class: 100000004865EUCTR2018-001917-34-ESConsorci Mar Parc de Salut de Barcelona400
招募中
不适用
Cardiovascular Offensive by the Medizinische Praxisnetz Neumünster e.V.I10Essential (primary) hypertensionDRKS00022325nterstützt mit Mitteln des Strukturfonds zur Förderung anerkannter Praxisnetze gemäß §87b SGB V der Kassenärztlichen Vereinigung Schleswig-Holstein (KVSH)600